HUTCHMED (China) (HMDCF) Invested Capital (2015 - 2026)
HUTCHMED (China)'s (HMDCF) quarterly Invested Capital came in at $1.4 billion in Q2 2026, up 2.55% year-over-year from $1.3 billion in Q2 2025, and up 1.86% quarter-over-quarter from $1.3 billion in Q4 2025.
Analysis
HUTCHMED (China) (HMDCF) Invested Capital (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Invested Capital for 12 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Invested Capital rose 2.55% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 2.55% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, changed N/A from the prior year.
- Invested Capital was $1.4 billion for Q2 2026 at HUTCHMED (China), up from $1.3 billion in the prior quarter.
- Over five years, Invested Capital peaked at $1.4 billion in Q2 2026 and troughed at $675.2 million in Q4 2022.
- A 5-year average of $1.0 billion and a median of $854.3 million in 2022 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital sank 36.8% in 2022 and surged 60.09% in 2025, its largest moves.
- Over 5 years, Invested Capital stood at $675.2 million in 2022, then advanced by 24.73% to $842.1 million in 2023, then fell by 0.95% to $834.1 million in 2024, then soared by 61.18% to $1.3 billion in 2025, then grew by 1.86% to $1.4 billion in 2026.
- The last three Invested Capital figures came in at $1.4 billion (Q2 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 74.44 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | 40.49 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 33.70 Bn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | 7.35 Bn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | 26.94 Bn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | - |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | 1.37 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.34 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Jun 30, 2024 | 834.12 Mn |
| Jun 30, 2023 | 842.12 Mn |
| Dec 31, 2022 | 675.18 Mn |
| Jun 30, 2022 | 854.33 Mn |
| Dec 31, 2021 | 1.07 Bn |
| Jun 30, 2021 | 1.04 Bn |
| Mar 31, 2021 | 455.14 Mn |
| Dec 31, 2020 | 573.07 Mn |
| Jun 30, 2020 | 393.89 Mn |
| Dec 31, 2019 | 340.09 Mn |
| Sep 30, 2019 | 339.28 Mn |
| Jun 30, 2019 | 375.83 Mn |
| Mar 31, 2019 | 434.54 Mn |
| Dec 31, 2018 | 445.26 Mn |
| Jun 30, 2018 | 495.22 Mn |
| Dec 31, 2017 | 515.42 Mn |
| Jun 30, 2017 | 263.75 Mn |